Lipitor Articles
Stock Commentary Tokyo
15 June 2000
Xenon and W-L sign $58M cholesterol deal
26 May 2000
Yamaanouci looks to Lipitor for future growth
24 May 2000
Takeda benefits from strong US showing
24 May 2000
Stock Commentary Tokyo
18 May 2000
Stock Commentary Tokyo
11 May 2000
W-L sets price for Lipitor in Japan
3 May 2000
Stock Commentary Tokyo
27 April 2000
US doctors wrote 9% more scripts last year
25 April 2000
Stock Commentary Tokyo
19 April 2000
Stock Commentary Tokyo
3 April 2000
Stock Commentary Tokyo
16 March 2000
Stock Commentary Tokyo
9 March 2000
Stock Commentary Tokyo
2 March 2000
Japan's Banyu upgraded by analysts
2 March 2000
Life after Losec at AstraZeneca
29 February 2000
Celebrex sets record for launch
24 February 2000
How the smaller firm can get the most out of its sales force
24 February 2000
Stock Commentary Tokyo
17 February 2000
Stock Commentary Tokyo
10 February 2000
Stock Commentary Tokyo
3 February 2000
Stock Commentary Tokyo
20 January 2000
Pfizer EPS in 4th qtr rises 56%
18 January 2000
Stock Commentary Tokyo
13 January 2000
Battle for Warner-Lambert continues
20 December 1999
Stock Commentary Tokyo
16 December 1999
Pfizer to try and eject W-L board
15 December 1999
Statin use in osteoporosis?
9 December 1999
Pfizer/Warner-Lambert continue their acrimonious argument
3 December 1999
Stock Commentary Tokyo
2 December 1999
Stock Commentary Tokyo
25 November 1999
Yamanouchi watching Lipitor developments
24 November 1999
Lawsuits and accusations fly as Pfizer steps up efforts to acquire
24 November 1999
Stock Commentary Tokyo
18 November 1999
Threat to Yamanouchi if Pfizer takes over Warner-Lambert?
16 November 1999
Sankyo licenses Cholestagel in USA
16 November 1999
W-L reviewing Lipitor deal; Pfizer fight hots up to scotch AHP plan
16 November 1999
B-MS and W-L go head-to-head with statins
10 November 1999
American Home Products confirms merger talks with Warner-Lambert
4 November 1999
American Home Products confirms merger talks with Warner-Lambert
3 November 1999
FDA requests drug interaction data for Pfizer's Relpax
26 October 1999
"Rising tide" of pharma consolidation reviewed by banker
21 October 1999
Cholesterol reduction in stroke prevention?
16 September 1999
World's top-selling drugs; 2002 forecasts
13 August 1999
Stock Commentary Tokyo
27 May 1999
High-dose Baycol cleared in USA
27 May 1999
Yamanouchi sales fall 11.3% in latest year
25 May 1999
Strong net profits growth for Sankyo
24 May 1999
NK-104 marketing deal in Japan
20 May 1999
Third-party payers lead Rx payments
5 May 1999
Kissei confident of sales and profit growth
30 March 1999
Schering-Plough heads S&P 500 health co list
29 March 1999
Stock Commentary New York
18 February 1999
Zeneca fast-tracks ZD4522 "superstatin"
15 February 1999
Stock Commentary New York
14 January 1999
Cholestagel filing planned for mid-year
12 January 1999
Merck "Get To Goal" Guarantee for Zocor
6 November 1998
First Approval Of New Higher-Dose Cerivastatin
5 November 1998
Novartis FAME Study For Primary Prevention In Elderly
4 November 1998
Healthy Third-Quarter Growth For US Drug Majors
22 October 1998
US Majors Post Strong Earnings For 3rd Quarter
15 October 1998
Warner-Lambert's Lipitor And Rezulin Will Fuel Growth
9 September 1998
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
